News Room

The United States could be the first country to launch one of the most ambitious vaccine operations in history: distributing and administering up to 600 million doses of a Covid-19 vaccine in just a few months. Massive vaccine campaigns are nothing new -- they have been carried out for decades in the fight against the measles and flu, for example. 

Yuri Levin, professor of Queen’s University Smith School of Business specializing in business analytics and artificial intelligence, takes up the position of Dean of Moscow School of Management SKOLKOVO.

Julie Swann, a professor of industrial and systems engineering at North Carolina State University, who advised the CDC during the H1N1 response, said she believes North Carolina will have all of the necessary logistics in place for mass distribution of a coronavirus vaccine as soon as one if approved.

The U.S. just reached a dark milestone: 10 million reported coronavirus cases. But there is also big news for a potential coronavirus vaccine. On November 9, Pfizer and German drugmaker BioNTech announced that data from their ongoing coronavirus vaccine trial shows the vaccine is more than 90% effective in preventing COVID-19, per the New York Times.

The duo's vaccine, known as BNT162b2, proved to be 90% effective after being tested on nearly 44,000 participants in its Phase III study.  This is a significant milestone in the fight against a virus that has infected more than 50 million people around the globe, resulting in over 1.2 million deaths. FOX Business takes a look at the key data points investors and consumers should know, as well as reactions from business and political leaders.